Free Republic 3rd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $13,038
16%  
Woo hoo!! And we're now over 16%!! Thank you all very much!! God bless.

Keyword: stenosis

Brevity: Headers | « Text »
  • World's most common heart valve disease linked to insulin resistance (Aortic stenosis)

    12/03/2024 9:40:53 PM PST · by ConservativeMind · 10 replies
    Medical Xpress / Taylor & Francis / Annals of Medicine ^ | Nov. 27, 2024 | Maija Sohlman et al
    A large population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world's most common heart valve disease—aortic stenosis (AS). Aortic stenosis is a debilitating heart condition. It causes a narrowing of the aortic valve, restricting blood flow out of the heart. If not addressed, this can gradually cause damage that can lead to life-threatening complications, such as heart failure. People living with AS can take years to develop symptoms, which include chest pain, tiredness, shortness of breath and heart palpitations. Insulin resistance, which often develops years before the onset...
  • Pope admitted to Rome hospital for 'scheduled' colon surgery

    07/04/2021 8:59:33 AM PDT · by BenLurkin · 35 replies
    bbc ^ | 07/04/2021
    In its statement, the Vatican said the pontiff needed treatment for "symptomatic diverticular stenosis" of the colon, part of the large intestine. Diverticular disease is a condition that involves bulges in the wall of the large intestine. This can lead to a narrowing, of the colon. Symptoms include bloating, recurrent abdominal pain and changes in bowel habits.
  • Israeli medical company receives FDA approval for life-saving tech

    07/07/2020 9:38:29 AM PDT · by EinNYC · 2 replies
    Jerusalem Post ^ | JULY 4, 2020 | TOBIAS SIEGAL
    Israeli company Endo GI Medical received approval from the US Food and Drug Administration (FDA) for its technology in the field of gastroenterology, a branch of medicine focused on the digestive system and its disorders, according to a press release by the company. The company, established in 2017 and headed by CEO Omri Nechmadi Nave, will now be shifting its focus towards receiving approval from the Israeli Health Ministry and starting marketing the technology for clinical use in Israel and the US. Endo GI Medical’s research and development includes the development of “Stenting Placement Delivery Systems for the treatment of...